3
Views
16
CrossRef citations to date
0
Altmetric
Original Article

Administration of a Retinoid as Prophylaxis of Recurrent Non-Invasive Bladder Tumors

, , , , , & show all
Pages 121-123 | Received 05 Jun 1983, Published online: 15 Feb 2010

REFERENCES

  • Alfthan, O., Tarkkanen, J., Gröhn, P., Heinonen, E., Pyrhönen, S. & Säilä, K. 1983. Tigason (Etretinate) in prevention of recurrence of superficial bladder tumors. Eur Urol 9, 6.
  • Bergkvist, A., Ljungqvist, A. & Moberger, G. 1965. Classification of bladder tumors based on the cellular pattern. Acta Chir Scand 130, 371.
  • Dowling, J. E. & Wald, G. 1960. The biological function of vitamin A acid. Proc Natl Acad Sci USA 46, 587.
  • Evard, J. P. & Bollag, W. 1972. Konservative Behandlung der rezidivierenden Harnblasenpapillomatose mit Vitamin-A-Säure. Schweiz Med Wschr 102, 1880.
  • Koontz, W., Flanagan, M., Ahmed, S., Penick, G., Prout, G. & Smith, W. 1981. Chemoprevention of bladder carcinoma with 13 cis-retinoic acid. Proc First Int Conf. on Bladder Cancer, Mt. Fuji, Japan.
  • Lund, F. & Lundwall, F. 1959. Epithelial tumours of the urinary tract. Follow-up and appraisal of the treatment of 480 cases. Dan med Bull 6, 59.
  • Schaerer, R., Swiercz, P., Mousseau, M. & Chabert, C. 1982. Is acid aromatic vitamin A (Ethretinate or “Tigason”) active in low grade malignant bladder carcinoma? Cancer Chemother Pharmacol 9 (Suppl), 50 (abstract).
  • Sporn, M. B., Squire, R. A., Brown, C. C. & Smith, J. M. 1977. 13-cis retinoic acid: Inhibition of bladder carcinogenesis in the rat. Science 195, 487.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.